DARTS I Feasibility Study

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 5, 2017

Primary Completion Date

August 21, 2019

Study Completion Date

March 19, 2024

Conditions
Aortic DissectionIntramural Hematoma
Interventions
DEVICE

AMDS

The device will be implanted during an already planned surgical intervention for aortic dissection repair. The participant will be observed and data gathered during the surgery and routine standard of care follow up visits.

Trial Locations (5)

T6G 2B7

Mazankowski Alberta Heart Institute, University of Alberta, Edmonton

N6A 5A5

London Health Sciences Center- University Hospital, London

M5G 2C4

University Health Network - Toronto General Hospital, Toronto

HIT 1C8

Montreal Heart Institute, Montreal

Unknown

Centre Hospitalier de I'Universite de Montreal (CHUM), Montreal

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Artivion Inc.

INDUSTRY

lead

Ascyrus Medical LLC.

INDUSTRY

NCT03035643 - DARTS I Feasibility Study | Biotech Hunter | Biotech Hunter